-+ 0.00%
-+ 0.00%
-+ 0.00%

PRESS RELEASE: SANOFI AND REGENERON’S DUPIXENT RECOMMENDED FOR EU APPROVAL TO TREAT CHRONIC SPONTANEOUS URTICARIA IN YOUNG CHILDREN WITH ONGOING SYMPTOMS DESPITE TREATMENT

Reuters·02/27/2026 12:03:23

Please log in to view news